These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 28571022

  • 1. Therapeutic Use Exemptions.
    Gerrard D, Pipe A.
    Med Sport Sci; 2017; 62():55-67. PubMed ID: 28571022
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic use exemptions (TUEs) at the Olympic Games 1992-2012.
    Fitch KD.
    Br J Sports Med; 2013 Sep; 47(13):815-8. PubMed ID: 23591601
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of therapeutic use exemptions at the Olympic Games and association with medals: an analysis of data from 2010 to 2018.
    Vernec A, Healy D.
    Br J Sports Med; 2020 Aug; 54(15):920-924. PubMed ID: 32376674
    [Abstract] [Full Text] [Related]

  • 4. The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology.
    Di Luigi L, Pigozzi F, Sgrò P, Frati L, Di Gianfrancesco A, Cappa M.
    J Endocrinol Invest; 2020 May; 43(5):563-573. PubMed ID: 31734891
    [Abstract] [Full Text] [Related]

  • 5. Doping control from a global and national perspective.
    Fraser AD.
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [Abstract] [Full Text] [Related]

  • 6. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M, Wagner U.
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [Abstract] [Full Text] [Related]

  • 7. The world anti-doping program and the primary care physician.
    Hilderbrand RL.
    Pediatr Clin North Am; 2007 Aug; 54(4):701-11, x-xi. PubMed ID: 17723872
    [Abstract] [Full Text] [Related]

  • 8. World anti-doping regulations for 2005: essential changes for athletes and physicians.
    Pabinger C, Gruber G.
    Arch Orthop Trauma Surg; 2006 May; 126(4):286-8. PubMed ID: 16333634
    [Abstract] [Full Text] [Related]

  • 9. Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.
    Fitch K.
    Clin Med (Lond); 2012 Jun; 12(3):257-60. PubMed ID: 22783779
    [Abstract] [Full Text] [Related]

  • 10. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S, Bowers LD, Fedoruk MN.
    Mo Med; 2015 Jun; 112(2):122-8. PubMed ID: 25958657
    [Abstract] [Full Text] [Related]

  • 11. Structure and Development of the List of Prohibited Substances and Methods.
    Kinahan A, Budgett R, Mazzoni I.
    Med Sport Sci; 2017 Jun; 62():39-54. PubMed ID: 28571027
    [Abstract] [Full Text] [Related]

  • 12. [Medicolegal aspects of doping in sports].
    Pruvost J, Depiesse F.
    Ann Readapt Med Phys; 2004 Aug; 47(6):263-73. PubMed ID: 15297116
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic Use Exemptions (TUEs) are essential in sport: but there is room for improvement.
    Fitch K.
    Br J Sports Med; 2020 Feb; 54(3):191-192. PubMed ID: 31000565
    [No Abstract] [Full Text] [Related]

  • 14. [Medication, athletes and doping regulations].
    Hartgens F.
    Ned Tijdschr Geneeskd; 2008 Aug 16; 152(33):1844-8. PubMed ID: 18783164
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of therapeutic use exemptions at the Olympic Games and Paralympic Games: an analysis of data from 2016 to 2022.
    Vernec A, Healy D, Banon T, Petroczi A.
    Br J Sports Med; 2024 Sep 04; 58(17):966-972. PubMed ID: 38981660
    [Abstract] [Full Text] [Related]

  • 16. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
    Striegel H, Rössner D, Simon P, Niess AM.
    Int J Sports Med; 2005 Apr 04; 26(3):238-43. PubMed ID: 15776342
    [Abstract] [Full Text] [Related]

  • 17. Strategies that athletes use to avoid detection of androgenic-anabolic steroid doping and sanctions.
    Alquraini H, Auchus RJ.
    Mol Cell Endocrinol; 2018 Mar 15; 464():28-33. PubMed ID: 28130115
    [Abstract] [Full Text] [Related]

  • 18. IGF-1 abuse in sport: clinical and medico-legal aspects.
    Molinelli A, Bonsignore A, Cicconi M, Cioè A, Traverso A.
    J Sports Med Phys Fitness; 2010 Dec 15; 50(4):530-5. PubMed ID: 21178942
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoids in elite sport: current status, controversies and innovative management strategies-a narrative review.
    Vernec A, Slack A, Harcourt PR, Budgett R, Duclos M, Kinahan A, Mjøsund K, Strasburger CJ.
    Br J Sports Med; 2020 Jan 15; 54(1):8-12. PubMed ID: 31326919
    [Abstract] [Full Text] [Related]

  • 20. Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games.
    Stuart M, Kwon YI, Rhie SJ.
    Br J Sports Med; 2019 Sep 15; 53(17):1105-1110. PubMed ID: 30894336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.